Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Takero, Shindo"'
Autor:
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hisashi Kato, Toshiki Uchida, Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon Seok Eom, Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo, Dok Hyun Yoon, Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/be870e753e614a74b756e1f3d6e51924
Autor:
Suguru Tamura, Hajime Ishiguro, Tatsuya Suwabe, Takayuki Katagiri, Kaori Cho, Kyoko Fuse, Yasuhiko Shibasaki, Tadahisa Mikami, Takero Shindo, Hiroshi Kitagawa, Michihiro Igarashi, Hirohito Sone, Masayoshi Masuko, Takashi Ushiki
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Donor T cell activation, proliferation, differentiation, and migration are the major steps involved in graft-versus-host disease (GVHD) development following bone marrow transplantation. Chondroitin sulfate (CS) proteoglycan is a major compo
Externí odkaz:
https://doaj.org/article/505d011b3c3b4c36bbbe1188c6e5bb1a
Autor:
Takahito Kawata, Takuya Shimizu, Takero Shindo, Kensuke Fujiwara, Suguru Morimoto, Mitsumasa Watanabe
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/904d05e5df8c4c0a91e95f30f7d4de72
Autor:
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Masahiro Yokoyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hirohiko Shibayama, Toshiki Uchida, Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon Seok Eom, Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo, Dok Hyun Yoon, Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
Tucidinostat (formerly known as chidamide) is an orally available, novel benzamide class of histone deacetylase (HDAC) inhibitor that selectively blocks class I and class IIb HDAC. This multicenter phase IIb study aimed to investigate the efficacy an
Externí odkaz:
https://doaj.org/article/1f6b47ace5124b24847722a0557d0ba2
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 61-68 (2021)
The development of BCR-ABL1 tyrosine kinase inhibitors (TKIs) markedly improved the prognosis of patients with chronic myeloid leukemia (CML). Approximately 50% of patients who achieve deep molecular response (DMR) remain in treatment-free remission
Externí odkaz:
https://doaj.org/article/c215c1291ff845a2a356c0a1d0b79248
Autor:
Makoto Iwasaki, Junya Kanda, Hidenori Tanaka, Takero Shindo, Takahiko Sato, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Tetsuya Eto, Naoyuki Uchida, Yuta Katayama, Keisuke Kataoka, Takahide Ara, Shuichi Ota, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The significance of antibody-identified epitopes stimulating humoral alloimmunity is not well understood in the identification of non-permissive human leukocyte antigen (HLA) mismatching patterns in hematopoietic stem cell transplantation (HSCT). Thi
Externí odkaz:
https://doaj.org/article/ff51bdc4514245ec9ec1f1d6a9249aef
Autor:
Hiroshi Okamura, Hirohisa Nakamae, Takero Shindo, Katsuki Ohtani, Yoshihiko Hidaka, Yasufumi Ohtsuka, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Naonori Harada, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Asao Hirose, Mika Nakamae, Nobutaka Wakamiya, Masayuki Hino, Norimitsu Inoue
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Transplant-associated thrombotic microangiopathy (TA-TMA) is a fatal complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous reports suggest that TA-TMA is caused by complement activation by complement-related gene
Externí odkaz:
https://doaj.org/article/fb59545219bd415fad1578d5717bd4f9
Autor:
Seiichiro Tada, MD, Takayuki Anazawa, MD, PhD, Takero Shindo, MD, PhD, Kei Yamane, MD, Kenta Inoguchi, MD, Nanae Fujimoto, MSc, Kazuyuki Nagai, MD, PhD, Toshihiko Masui, MD, PhD, Hideaki Okajima, MD, PhD, Kyoichi Takaori, MD, PhD, Shoichiro Sumi, MD, PhD, Shinji Uemoto, MD, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 9, p e591 (2020)
Background. Potential adverse effects, such as functional impairment of islets, render conventional immunosuppressive drugs unsuitable for use in islet transplantation. In addition, as a single therapy, they cannot prolong islet allograft survival. H
Externí odkaz:
https://doaj.org/article/782c36f360b94599afaabfcea21df638
Publikováno v:
European Journal of Cancer. 176:189-192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d9a0fb80303a8c36fd25bb689edb43
https://doi.org/10.1016/j.ejca.2022.09.015
https://doi.org/10.1016/j.ejca.2022.09.015
Autor:
Shinya Kimura, Atsushi Kawaguchi, Hiroh Saji, Hidenori Tanaka, Yuki Miyazaki, Yasushi Kusunoki, Hiroto Kojima, Takero Shindo, Hiroshi Ureshino
Response to tyrosine kinase inhibitors (TKIs) is variable in chronic myeloid leukemia (CML), and elevated natural killer (NK) cells during TKI therapy are positively correlated with superior outcomes. NK cell function involves interactions of their k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4466ebf47724bdbfbffbeebde69c16e1
https://doi.org/10.1158/2326-6066.c.6549179.v1
https://doi.org/10.1158/2326-6066.c.6549179.v1
